Abstract. Upstream stimulatory factor (USF) has a negative effect on the cell proliferation in some cell types. However, its effect on thyrocytes is not clear. Therefore, we investigated the effects of USF on the proliferation and function of thyroid follicular cells. Complementary DNAs of the USF-1 and USF-2 were synthesized using RT-PCR from FRTL-5 cells, and each was transfected to FRTL-5 cells and papillary thyroid carcinoma cell lines. Cyclic AMP (cAMP) production and [methyl-3 H] thymidine uptake after thyroid stimulating hormone (TSH) treatment were measured in FRTL-5 cells. In the carcinoma cell lines, 5-bromo-2'-deoxyuridine (BrdU) uptake was assayed to evaluate cell proliferation. Apoptosis was tested by Hoechst staining and cell cycle analysis was done using a fluorescence activated cell sorting. Expression of cell cycle regulating genes was evaluated by Northern and Western blotting. Overexpression of USF-1 and USF-2 significantly suppressed TSH-stimulated [methyl-3 H] thymidine uptake (p<0.05), while it maintained TSH-stimulated cAMP production in FRTL-5 cells. Overexpression of USF significantly suppressed BrdU uptake in each carcinoma cell line, NPA and TPC-1 cells (p<0.05). It induced delay of cell cycle at the G2/M phase, but did not increase apoptosis in FRTL-5 cells. It was accompanied by a decrease of cyclin B1 and cyclin-dependent kinase (CDK)-1, and an increase of p27 expression. USF-1 and USF-2 suppressed cell proliferation of normal thyrocytes and thyroid carcinoma cells. However, they retained the ability to produce cAMP after TSH stimulation. Their inhibitory effect on cell proliferation might be caused partly by the delay in G2/M phase.
UPSTREAM stimulatory factor (USF) is a transcription factor ubiquitously expressed in most tissues and cell lines [1, 2] . Two different genes, defined as USF-1 and USF-2, encode the 43 and 44 kDa polypeptides, respectively [3] [4] [5] [6] . These two peptides have identical DNA-binding specificities and transcriptional activities [3] [4] [5] 7] . They share a highly conserved C-terminal basic/helix-loop-helix/leucine zipper sequence, which is important to the dimerization and DNA-binding of USF [3, 4, [8] [9] [10] . USF is known to inhibit cell proliferation in some cell types [11] [12] [13] [14] . The inhibitory effect on the cell proliferation might be accomplished by antagonizing the transforming function of Myc or its binding to promoter sequences as well as specific protein/protein interactions [13, 14] . This inhibition might be controlled by interactions with a specialized coactivator that recognizes the USF-specific domain region [11] . However, its effect on thyrocytes and the exact mechanism responsible for negative regulation of cell proliferation remains unclear. Therefore, we investigated the effects of USF on the proliferation and function of FRTL-5 cells and thyroid carcinoma cells and identified the mechanism responsible for regulation of cell proliferation.
Materials and Methods

Maintenance of cells
Fresh F1 subclone of FRTL-5 cells (Interthyr Research Foundation, Baltimore, MD, USA) was grown in 6H medium. Fresh medium was replaced every 3 days and cells were passed every 7-10 days. The NPA cell line is a poorly differentiated papillary thyroid carcinoma cell line and was maintained in RPMI 1640. TPC-1 cells, a well-differentiated papillary thyroid carcinoma line, were cultured in Dulbecco's modified Eagle's medium. Both cell lines were obtained from Dr. Minho Shong (Chungnam National University College of Medicine, Daejeon, Korea), and the medium was changed every other day. All cells were grown at 37°C in 5% CO 2 -95% O 2 .
Electrophoretic mobility shift assay (EMSA)
Nuclear proteins from TSH-stimulated and nonstimulated FRTL-5 cells were prepared as described by Suzuki et al. [15] . Protein concentrations were determined using Bio-Rad kit (Hercules, CA, USA). EMSA was performed using 5 µg of nuclear extracts. A probe with sodium-iodide symporter (NIS) promoter region (-2462 to -2429 base pair) was synthesized by labeling with [γ-32 P] ATP and T4 polynucleotide kinase (New England Biolabs). The binding buffer consisted of 20 mM HEPES (pH 7.9), 10% glycerol, 5 mM MgCl 2 , 50 mM KCl, 1 mM EDTA, 0.1% Nonidet P-40, and 2 µg of poly (dI-dC)-poly (dI-dC). The probe (50,000 cpm) was added to the nuclear proteins and the sample was incubation for 20 min at room temperature. DNAprotein complexes were separated through nondenaturated 5% acrylamide gels at room temperature. Gels were dried and autoradiographed.
Construction of cDNAs and cloning
Total RNA was extracted from the FRTL-5 cells using an RNA extraction kit (Invitrogen, Carlsbad, CA, USA), and the amount was measured by spectrophotometer (Pharmacia, Buckinghamshire, England). Two micrograms of RNA mixed with 0.1% DEPCtreated distilled water were incubated for 5 min at 70°C. The cDNA was synthesized using a commercial kit (AccuPower RT PreMix, BiONEER, Daejeon, Korea). PCR for USF-1, -2, Pax-8, and thyroid transcription factor (TTF)-1 was performed in a 20 µL reaction mixture containing 5 µL of denatured cDNA, 250 µM of dNTP mix, 2.5 U of Taq DNA polymerase (BiONEER, Daejeon, Korea), 20 mM of Tris-HCl (pH 8.8), 10 mM of KCl, 2 mM of MgSO 4 and 0.5 µM of each primer (primer sequences for USF-1, -2, Pax-8, and TTF-1 are listed in Table 1 ). PCR was carried out in a thermal cycler GeneAmp 9600 PCR apparatus (Perkin-Elmer Corp., Norwalk, CT, USA) as follows: initial denaturation at 95°C for 5 min, 30 cycles of denaturation (94°C, 1 min), annealing (52 to 60°C, 1 min), extension (72°C, 2 min) and final extension at 72°C for 10 min. The PCR products were electrophoresized in a 1.5% agarose gel.
The PCR products were purified from the gel using a kit (PCRquick-spin PCR Product Purification Kit, iNtRON Biotechnology, Sungnam, Korea), and then cloned into the pcDNA3.1 vectors using a pcDNA3.1/ V5-His TOPO TA expression kit (Invitrogen, Carlsbad, CA, USA). The cDNA was extracted from a cloned vector using a QIAprep Spin Miniprep kit (QIAGEN Inc., Valencia, CA, USA). Gene sequencing was performed in 2~3 clones for each cDNA using an automated direct sequencing analyzer (ABI PRISM, 377 DNA sequencer, Perkin Elmer, Foster City, CA, USA), and identical clones with references (USF-1, NM_031777; USF-2, NM_011680; Pax8, NM_031141; TTF-1, X_53858) were used for transfection. 
* primer sequence of rat, † primer sequence of mouse
Transfection of cloned cDNA into cells
FRTL-5 cells
FuGENE6 (Roche Diagnostics, Mannheim, Germany) was used to transfect DNA plasmids into FRTL-5 cells. The average transfection efficiency into FRTL-5 cells was 15 to 30%.
For cAMP and proliferation assay, FRTL-5 cells were grown to 80% confluency in 6H medium and then shifted to 5H medium (6H medium minus TSH) for 3-5 days to make cells quiescent. The cells were transfected with the interested plasmids at a FuGENE6 : DNA ratio of 3 : 2 (vol : µg), per the manufacturer's instructions. Twenty-four h after the outset of transfection, TSH was added to the medium for 24 h (cAMP assay) or 36 h (proliferation assay).
For western and cell cycle analysis, FRTL-5 cells were grown to 50-60% confluence in 6H medium and then shifted to 0.2% calf serum-4H medium (without TSH, Insulin) for 3 days. Eighteen h before transfection, the medium was changed to 6H. Then, they were transfected with either the pcDNA3 vector (5 µg) or the USF-1,2 expression vector (5 µg) plus an expression vector coding for green fluorescent protein (5 µg, pEGFP; Clontech, Sydney, Australia) in case of cell cycle analysis. Thirty or fifty hours after transfection with FuGene6, the cells were harvested.
NPA and TPC-1 cells
For transfection, NPA and TPC-1 cells were incubated with serum free media for 4 h, and then transfected using Lipofectamine Plus (Invitrogen, Carlsbad, CA, USA). After 24 h of transfection, the cells were fed with complete medium, and after 24 h, cell proliferation was evaluated.
All the transfection experiments were performed in duplicate.
Measurement of cAMP in FRTL-5 cells
The concentrations of extracellular cAMP were measured using the cAMP EIA system (Amersham Pharmacia Biotech, Piscataway, NJ, USA).
[Methyl-3 H] thymidine uptake assay and BrdU incorporation
Two µCi/well of [methyl-3 H] thymidine (PerkinElmer, Wellesley, MA, USA) were added to medium, and incubated for 6 h. Cells were washed with cold PBS and incubated with 5% trichloroacetic acid for 20 min at room temperature. Cells were re-incubated with 0.5 N KOH overnight. [Methyl-3 H] thymidine uptake was counted using a Multi-purpose scintillation counter (Beckman, USA).
In the experiments with carcinoma cell lines, 5-bromo-2'-deoxyuridine (BrdU) incorporation was measured using a quantitative ELISA kit (Cell proliferation ELISA, Roche, Germany).
Northern blot analyses
Total RNA was prepared from FRTL-5 cells either stimulated with TSH (1 × 10 -10 M) or transfected with USF-1 using a commercial kit (Qiagen Inc., Valencia, CA). Fifteen micrograms of the RNA samples were run on denatured agarose gels, capillary blotted on Nytran membranes, UV cross-linked, and subjected to hybridization. Full length rat USF-1, mouse USF-2, rat β-actin, rat cyclin B1, and GAPDH were used as probes; radiolabeling was performed as described [15] . Quantitation was performed using a BAS 1500 Bioimaging Analyzer (FUJI Medical Systems USA, Inc., Stamford, CT).
Western blot analysis
Total proteins were obtained with RIPA buffer supplemented with NaF, Na 3 VO 4 , PMSF and complete protease inhibitor cocktail tablets (Roche, Germany). Protein concentrations were determined using Bio-Rad kit (Hercules, CA, USA). Twenty micrograms of protein was separated on 10% SDS-PAGE, transferred to nitrocellulose membranes, blocked in 5% skim milk, and incubated with antibodies. SuperSignal ® West Femto Maximum Sensitivity Substrate (Pierce, Rockford, IL, USA) was used to detect specific bands. All antibodies were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA); their catalog numbers are as follows: USF-1, sc-229; USF-2, sc-86; p27, sc-528; CDK-1, sc-747; cyclin B1, sc-752; tubulin, sc-5546. Densitometry program used for band intensity measurement was Image Lab (version 2.2.4.0, MCM DESIGN, Denmark).
Cell cycle analysis and Hoechst staining
The cells were cotransfected with either 5 µg of pcDNA3.1 vector or 5 µg of USF expression vector together with an expression vector coding for green fluorescent protein (5 µg, pEGFP; Clontech, Sydney, Australia). Thirty or fifty h after transfection with FuGENE6, the cells were trypsinized and fixed with 70% cold ethanol for 12 h at 4°C. After washing with PBS, the cells were incubated in PI/RNase staining buffer (BD Biosciences PharMingen) for 10 min at 37°C in the dark. The cells were then subjected to cellcycle analysis employing a FACS Vantage (BD Bioscience, San Jose, CA, USA). GFP-positive cells were gated by fluorescence-activated cell sorting (FACS) prior to assessing the cell-cycle distribution. At least 10,000 GFP-positive events were collected and the data were analyzed using the ModFit LT3.0 software.
Cells with apoptotic bodies were detected by staining with Hoechst 33342 on GFP-containing cells and fluorescence microscopy.
Statistical significance
All experiments were repeated at least three times with different batches of cells. The data were analyzed using the SPSS-PC software program (version 11.5, Chicago, IL, USA). P values less than 0.05 were considered significant. Statistical significance was determined by two-way analysis of variance (ANOVA) and Student t-test. All values were expressed as mean ± SD.
Results
Effects of TSH on the USF binding to NIS promoter and mRNA expression of USF in FRTL-5 cells TSH, the main hormonal regulator of thyroid function and proliferation, stimulates thyroidal iodide accumulation and NIS gene expression [16, 17] . FRTL-5 cells grown without TSH were treated with 1 × 10 -10 M TSH for 24 h, and then nuclear extracts were prepared. In EMSA using NIS promoter as a radiolabeled probe (Fig. 1A) , it was clear that TSH decreased USF complex formation.
The ability of TSH to decrease USF binding was associated with a TSH-induced decrease in USF-1 mRNA levels (Fig. 1B) . These findings suggested that USF might be associated with TSH-stimulated cell proliferation in the thyrocytes.
Effects of USF on the cAMP production and cellular proliferation in FRTL-5 cells
Transient transfection with vectors of some transcription factors induced overexpression of them in FRTL-5 cells. Overexpression of USF was shown in Fig. 6 and 7 . Compared to the cells transfected with pcDNA3.1, TSH-stimulated cAMP production was increased with overexpression of USF-1 and USF-2, but TSH-stimulated [methyl-3 H]-thymidine uptake was significantly decreased (p<0.05, Fig. 2 ). It means USF enhances the TSH-stimulated cAMP production while suppresses TSH-stimulated cell proliferation. By contrast, overexpression of other thyroid-specific transcription factors, such as TTF-1 and Pax-8, maintained or increased both cAMP production and cell proliferation after TSH stimulation (Fig. 3) . Therefore, overexpression of USF-1 or -2 showed different results in thyrocytes compared with known thyroid-specific transcription factors. (B) FRTL-5 cells were exposed to 1 × 10 -10 M TSH for indicated periods. RNA was isolated from each set, and Northern analysis using USF probes was performed. TSH treatment decreased mRNA levels of USF-1 and USF-2 in time-dependent manner.
Effect of USF on the cellular proliferation in papillary thyroid carcinoma cells
We studied the anti-proliferative effects of USFoverexpression in papillary thyroid carcinoma cells. Transient transfection of transcription factors induced overexpression in papillary thyroid carcinoma. Overexpression of USF-1 and USF-2 significantly decreased BrdU uptake in NPA and TPC-1 cells (p<0.05, Fig. 4 ). Reduction in BrdU uptake was more prominent in the USF-2-transfected cells (63% reduction in NPA, p<0.01; 49% reduction in TPC-1, p<0.05). Overexpression of TTF-1 and Pax-8 had no suppressive effect on the BrdU uptake in these cells (Fig. 4) . As a result, we observed that overexpression of USF but not of TTF-1 or Pax-8 suppressed cellular proliferation in papillary thyroid carcinoma cells, as in FRTL-5 cells.
Effect of USF on the apoptosis in FRTL-5 cells
Apoptosis in FRTL-5 cells that were transfected with USF-1 and USF-2 was evaluated by Hoechst staining. Induction of apoptosis was not observed in the cells with overexpression of USF-1 and USF-2. Therefore, the anti-proliferative effect of USF in thyrocytes was not achieved through apoptosis.
Effects of USF on the cell cycle progression and the cell cycle regulating genes in FRTL-5 cells FRTL-5 cells were transfected with USF expression vector in conjunction with GFP expression vector. The GFP-positive cells were subjected to cell-cycle analy- sis. Overexpression of USF-1 and USF-2 delayed FRTL-5 cell cycle in G2/M phase. The G2/M phase delay was prominent in the cells incubated for 50 h after transfection (37% for pcDNA3.1, 48% for USF-1, and 52% for USF-2; Fig. 5 ) while it was not definite at 30 h after transfection. mRNA and the protein expression of cell cycleregulating genes were measured via Northern and Western blotting (Fig. 6 and 7) . mRNA expression of cyclin B1 was decreased by overexpression of USF-1. Protein levels of cyclin B1 and CDK1 which are necessary in progression of G2/M phase were decreased while those of CDK inhibitor, p27 were increased in USF-overexpressed FRTL-5 cells. These results would contribute to the G2/M phase delay observed in USF-overexpressed FRTL-5 cells.
Discussion
USF has been reported to inhibit cell proliferation in the rat embryo fibroblast and other cells [11, 13, 14] .
Loss of its transcriptional activity has been identified in breast cancer cells [12] . However, the anti-proliferative effect of USF is not common in most cell types. A Saos-2 osteosarcoma cell line was not inhibited in its proliferation by USF [11] . Effects of USF on thyroid follicular cells and thyroid carcinoma cells have not yet been reported. Incidence and prevalence of thyroid cancer is sharply increasing in some countries including Korea [18] [19] [20] [21] , but there has been no effective preventive method for it. If USF is associated with TSH-stimulated thyrocyte proliferation, it may confer a base for it. Therefore, we investigated the effect and mechanism of USF on TSH-stimulated thyrocyte proliferation.
First, we found that TSH, a potent stimulator of thyroid cell proliferation, decreased mRNA expression and DNA binding of USF (Fig. 1) . TSH induces thyroid cellular function and proliferation, as its name suggests. Development of thyroid gland and its functional response to TSH are dependent on the thyroid-specific genes such as thyroglobulin, TSH-receptor, sodiumiodide symporter (NIS), thyroperoxidase, etc. These Overexpression of USF-1 and/or USF-2 significantly decreased BrdU uptake in both cell lines (p<0.05). Reduction in BrdU uptake was more prominent in the cells with overexpression of USF-2. Overexpression of TTF-1 and Pax-8 had no effect on the BrdU uptake in these cells.
thyroid-specific genes rely on the coordinated action of a master set of transcription factors: the homeodomain protein TTF-1 and the paired-domain protein Pax-8 [22] . In this study, cAMP (a second messenger of TSH) was measured to evaluate thyroid cellular function after TSH treatment. The effects of USF on the TSH-stimulated cAMP production and cellular proliferation was compared to those of TTF-1 and Pax-8, which are known transcription factors important to both phenomena. As seen in Fig. 2 , overexpression of USF-1 and USF-2 increased TSH-stimulated cAMP production, but suppressed TSH-stimulated cell proliferation in FRTL-5 cells. This means that USF overexpression inhibits cell proliferation without impairment of cellular function in thyrocytes. By contrast, overexpression of TTF-1 and Pax-8 maintained cAMP production and cell proliferation after TSH stimulation (Fig. 3) . There has been no report on the production of cAMP and USF overexpression directly. Corre et al.
showed UV-mediated skin pigmentation through alphamelanocyte-stimulating hormone and its receptor was mediated by p38 stress-activated kinase signaling to USF-1 [23] . Alpha-melanocyte-stimulating hormone and its receptor regulate the intracellular levels of cAMP. Therefore, this suggests that USF-1 and cAMP levels have some relationship. In some cell types, USF and cAMP response element-binding protein (CREB) compete the DNA binding [24, 25] . Therefore, we can speculate that overexpression of USF might inhibit the function of CREB and a feedback mechanism may increase cAMP levels in FRTL-5 cells. This assumption needs further study on the genes that regulate cAMP production in thyroid cells. The suppressive effect of USF on cell proliferation was also observed in papillary thyroid cancer cell lines, but neither TTF-1 nor Pax-8 suppressed the proliferation of carcinoma cells. These findings suggested that USF-1 and USF-2 might play a role in the negative regulation of thyroid cell proliferation. USF has been reported to inhibit cell proliferation by antagonizing the transforming function of the Myc oncoprotein [14] . Although USF protein shares a similar structure and DNA-binding specificity with Myc, both play antagonistic roles in the control of mammalian cell proliferation [11, 14, [26] [27] [28] . USF has also been reported to interfere with Ras-driven transformation and enhance transcriptional activity of p53 [13, 29] . The cell typedependent anti-proliferative effect of USF might be achieved through its binding to promoter sequences and specific protein/protein interactions, and this process might be controlled by interaction with a specialized coactivator [11, 13] . However, the exact mechanism responsible for suppression of cellular proliferation is not clear. From these findings, we speculated that USF might exert an inhibitory effect on cell proliferation through the activation of cell cycle regulatory proteins after binding to its promoter. USF has been reported to play an important role in gene expression [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] . Recently, Cogswell et al. reported that USF-1 binds to a specific site on the cyclin B1 promoter, and this binding is induced in G2/M phase-blocked cells [32] . North et al. reported that USF regulated CDC2 (also known as CDK1) gene expression [38] . They suggested that USF might be a G2 phase-specific control protein for cyclin B1 and CDK1. Therefore, we investigated the effects of USF on the progression of the cell cycle, as well as the expression of cell cycle regulatory genes. We performed Hoechst staining to exclude the possibility of apoptosis and then FACS analysis. In this study, we could not observe the induction of apoptosis by USF overexpression. Instead of apoptosis, we observed that USF-1 and USF-2 delayed the FRTL-5 cell cycle in the G2/M phase. Expression of mRNA and proteins regulating the progression of G2/M phase such as cyclin B1 and CDK1 was decreased. But expression of CDK inhibitor such as p27 was increased. These results suggested that both USF-1 and USF-2 inhibit cell proliferation by delay of cell cycle, especially in the G2/M phase, not by apoptosis. The G2/M phase delay was induced by modifying the expression of cyclin B1, CDK1, and p27. Although we did not perform these studies with NPA or TPC-1 cells, the mechanisms by which USF downregulated the cell proliferation in the carcinoma cell lines may be similar to those in FRTL-5 cells. Further evaluation on the mechanisms with NPA or TPC-1 cells will be necessary later. Phase-specific cyclin-CDK complexes regulate cell cycle progression, which are associated with the synthesis and degradation of specific cyclins. The CDKs are serine/threonine protein kinases that are activated at specific points in the cell cycle [39] . The appropriate dephosphorylation of a specific CDK and its binding to a specific cyclin is necessary for activation. Activated CDK1 and cyclin B are required for the transition from G2/M to the next phase [39] [40] [41] . Induction of G2/M phase delay is thought to occur mainly by phosphorylation of CDK1. Wee1 protein kinase phosphorylates and inactivates CDK1, but CDC25C phosphatase dephosphorylates and activates it [39, [42] [43] [44] [45] [46] [47] [48] . The p21 family includes p21 (also known as waf1, cip1, and pic1), p27 (kip1), and p57 (kip2) [39, 48, 49] . The p27 inhibits most CDKs and is of primary importance in the regulation of G1 phase [39, 50] . However, the p27 has been implicated in G2 delay in a variety of cell types [51] [52] [53] . The p27 as well as Wee1 appear to play a role in G2/M phase delay in some cells. In summary, our findings suggested that both USF-1 and USF-2 played a role in suppressing the cell proliferation of normal thyrocytes and papillary thyroid carcinoma cells. However, they retained the ability to produce cAMP after TSH stimulation. Their antiproliferative effects could be ascribed to G2/M phase delay by modifying the expression of cell-cycle regulating proteins. 
